Cytosorbents
About:
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
Website: http://cytosorbents.com
Twitter/X: cytosorbents
Top Investors: Avenue Capital Group, U.S. Department of Defense, Bridge Bank, U.S. Army Medical Research & Development Command
Description:
CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.
$105M
$10M to $50M
Monmouth Junction, New Jersey, United States
1997-01-01
info(AT)cytosorbents.com
Frank Clark
101-250
2024-07-02
Public
© 2025 bioDAO.ai